高龄老人血脂异常管理专家共识

2022-04-15 江苏卫生保健

血管疾病的患病率随年龄增长显著升高。在心血管疾病中高脂血症是重要危险因素,积极控制血脂异常可显著降低心血管病患病率和死亡率早已成为临床共识。老年人的代谢会发生许多变化,同时也合并更多的疾病,如糖尿病、

中文标题:

高龄老人血脂异常管理专家共识

发布机构:

发布日期:

2022-04-15

简要介绍:

血管疾病的患病率随年龄增长显著升高。在心血管疾病中高脂血症是重要危险因素,积极控制血脂异常可显著降低心血管病患病率和死亡率早已成为临床共识。老年人的代谢会发生许多变化,同时也合并更多的疾病,如糖尿病、慢性肾脏病等。因此,老年人的血脂异常管理存在一定的特殊性。

相关资料下载:
[AttachmentFileName(sort=1, fileName=高龄老人血脂异常管理专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=793a81c002a29659, title=高龄老人血脂异常管理专家共识, enTitle=, guiderFrom=江苏卫生保健, authorId=0, author=, summary=血管疾病的患病率随年龄增长显著升高。在心血管疾病中高脂血症是重要危险因素,积极控制血脂异常可显著降低心血管病患病率和死亡率早已成为临床共识。老年人的代谢会发生许多变化,同时也合并更多的疾病,如糖尿病、, cover=https://img.medsci.cn/20220505/1651757209300_5579292.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Apr 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">血管疾病的患病率随年龄增长显著升高。在心血管疾病中高脂血症是重要危险因素,积极控制血脂异常可显著降低心血管病患病率和死亡率早已成为临床共识。老年人的代谢会发生许多变化,同时也合并更多的疾病,如糖尿病、慢性肾脏病等。因此,老年人的血脂异常管理存在一定的特殊性。</span></p>, tagList=[TagDto(tagId=3785, tagName=血脂异常)], categoryList=[CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6946, appHits=227, showAppHits=0, pcHits=697, showPcHits=6714, likes=3, shares=32, comments=4, approvalStatus=1, publishedTime=Fri May 06 15:25:00 CST 2022, publishedTimeString=2022-04-15, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu May 05 21:29:22 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 05:02:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高龄老人血脂异常管理专家共识.pdf)])
高龄老人血脂异常管理专家共识.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239901, encodeId=6430123990185, content=<a href='/topic/show?id=9cb88991048' target=_blank style='color:#2F92EE;'>#血脂#</a><a href='/topic/show?id=53cc899384b' target=_blank style='color:#2F92EE;'>#血脂管理#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89910, encryptionId=9cb88991048, topicName=血脂), TopicDto(id=89938, encryptionId=53cc899384b, topicName=血脂管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Aug 20 07:04:39 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224278, encodeId=89b512242e83c, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 03 19:07:16 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219201, encodeId=cb8f121920151, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu May 12 22:44:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217869, encodeId=4932121e86930, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1288151702, createdName=ms1000000864922836, createdTime=Sun May 08 15:53:02 CST 2022, time=2022-05-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1239901, encodeId=6430123990185, content=<a href='/topic/show?id=9cb88991048' target=_blank style='color:#2F92EE;'>#血脂#</a><a href='/topic/show?id=53cc899384b' target=_blank style='color:#2F92EE;'>#血脂管理#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89910, encryptionId=9cb88991048, topicName=血脂), TopicDto(id=89938, encryptionId=53cc899384b, topicName=血脂管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Aug 20 07:04:39 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224278, encodeId=89b512242e83c, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 03 19:07:16 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219201, encodeId=cb8f121920151, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu May 12 22:44:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217869, encodeId=4932121e86930, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1288151702, createdName=ms1000000864922836, createdTime=Sun May 08 15:53:02 CST 2022, time=2022-05-08, status=1, ipAttribution=)]
    2022-06-03 ms6000000225486324

    学习了,很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1239901, encodeId=6430123990185, content=<a href='/topic/show?id=9cb88991048' target=_blank style='color:#2F92EE;'>#血脂#</a><a href='/topic/show?id=53cc899384b' target=_blank style='color:#2F92EE;'>#血脂管理#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89910, encryptionId=9cb88991048, topicName=血脂), TopicDto(id=89938, encryptionId=53cc899384b, topicName=血脂管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Aug 20 07:04:39 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224278, encodeId=89b512242e83c, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 03 19:07:16 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219201, encodeId=cb8f121920151, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu May 12 22:44:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217869, encodeId=4932121e86930, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1288151702, createdName=ms1000000864922836, createdTime=Sun May 08 15:53:02 CST 2022, time=2022-05-08, status=1, ipAttribution=)]
    2022-05-12 未来将来

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1239901, encodeId=6430123990185, content=<a href='/topic/show?id=9cb88991048' target=_blank style='color:#2F92EE;'>#血脂#</a><a href='/topic/show?id=53cc899384b' target=_blank style='color:#2F92EE;'>#血脂管理#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89910, encryptionId=9cb88991048, topicName=血脂), TopicDto(id=89938, encryptionId=53cc899384b, topicName=血脂管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Aug 20 07:04:39 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224278, encodeId=89b512242e83c, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 03 19:07:16 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219201, encodeId=cb8f121920151, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu May 12 22:44:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217869, encodeId=4932121e86930, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1288151702, createdName=ms1000000864922836, createdTime=Sun May 08 15:53:02 CST 2022, time=2022-05-08, status=1, ipAttribution=)]
    2022-05-08 ms1000000864922836

    学习了

    0